HHSE Blog: July looks to be a busy time for HHSE! Friday,

New Post Public Reply Private Reply Replies (0) Message Board
martyj1
264
HHSE Blog: July looks to be a busy time for HHSE! Friday, June 29, 2018

Happy Friday to our HHSE Friends & Followers - Corporate movements are kicking into third gear for July, with material activities on multiple fronts, and lots of meetings and travel support.

The Launch of MYFLIX requires two L.A. trips during July - plus one web-hosting visit to Seattle. The L.A. trip will also allow for some face-to-face meetings with key MYFLIX suppliers and other major studios that we are seeking to enlist. The aggressive Q3 / Q4 home video & digital release slate for the HHSE / Medallion core distribution business will also benefit from direct meetings with key wholesalers and distribution partners in the L.A. metro. And of course, we anticipate one or more day trips during July to meet with the auditors (current Form 10 project), should issues requiring clarification not be easily resolved by calls or Skype.

Hannover's original production of the Period-Thriller, THE RIOT ACT, will likely be rescheduled for theatrical release in SEPTEMBER in order to access a retail cross promotion and a College / Universities support campaign. Previously, we had planned this title for theatrical launch on Aug. 24... but the mid-to-late September date is looking more interesting. HHSE / Medallion also have two other titles for theatrical release - both planned for OCTOBER (neither acquisition has yet been announced, so out of respect for the stature of the films, the company will announce the titles via separate wire-services press releases).

With all of this exciting activity and results, some current and prospective shareholders are asking about the HHSE stock and timing. Accordingly, we share with you below the summation of notes from large traders / professional funds that have been in communication with HHSE management over the past few months.

WHY IS THIS A GREAT TIME TO LOOK AT HHSE?

1). STABILITY - Company has been in business for 25-years (since 1993).

2). DIVERSITY
- Original business of BOOK PUBLISHING evolved into DVD Distribution and now into THEATRICAL and INTERNATIONAL Distribution as market conditions changed.

3). NEW MEDIA
- the new MYFLIX Venture into digital streaming (www.MyFlix.com), has over 30-studio and film library participants, collectively with over 10,000 feature films and television episodic hours of entertainment. This platform will have (literally) THOUSANDS of movies not available on any other streaming site. Less than ten years ago, NETFLIX was a mail order video rental business. NOW they are among the top movers and shakers in the entertainment industry DESPITE having a very limited selection of programming for viewers. We believe that MYFLIX could be a revolutionary new streaming destination - and a massive turning point for Hannover House.

4). STOCK REGISTRATION - HHSE is currently on the "OTC-Pinksheets" exchange. This status has impeded some large, institutional investors and hedge funds from buying into the stock. However, the pending Form 10 filing (including audits), will elevate the stock to the OTC:QB status as an initial step towards possible further up-listing. The OTC:QB status will open the door to significant new shareholders, which most professional traders and investors feel will dramatically improve the PPS and trading volume for HHSE.

5). NO STOCK ISSUANCES / NO DILUTION - HHSE has not issued any new shares in the past three years, and management has repeatedly stated that there are no plans to dilute shareholders through any deals now in motion or anticipated in the future.

6). PRESENTLY UNDER-VALUED PPS - Based on the Price-Earnings ratio for other publicly traded film / entertainment distributors, HHSE should be enjoying a 22X share price based on earnings. HHSE is on target to realize $1,250,000 in earnings for FYE 12-31-2018. This supports a share price of $.034 at present... and does not take into account the tremendous good-will and enthusiasm factor for the upcoming launch of MyFlix. Some highly respected stock analysts have communicated to HHSE management their prediction that the company's activities could support a share price of $.15 - which is more than ten-times current pricing. Even if their predictions are off by 75% - there is still an easily justifiable share price that is many times more than current trading levels.

7). TIMING-TIMING-TIMING
- The launch of Myflix is a "second generation" site, in that the digital streaming technology and consumer acceptance have already been established. With that essential battle already won, MyFlix can concentrate on becoming "the better mousetrap" for digital entertainment. You combine this ideal market timing with the company's stock registration uplist, the presence of significant new shareholders post-registration, and new distribution pacts for the company's core film distribution activities (SONY / CINEDIGM), many feel that NOW is the ideal time to take a position in HHSE shares (while the HHSE Price Per Share is artificially low). Are these professional traders right? We will all know very soon!

HHSE makes no representation, guarantee or warranty that our share price will improve significantly as a result of these and other current activities. Every stock investment involves risks and factors outside of the control of issuers and management. But we proudly share with you the above information, projections and rationale' that professional traders have identified as the basis for why they believe that NOW is a great time to look at HHSE.

CHECK THIS BLOG SITE FOR REGULAR UPDATES ON HHSE and MYFLIX!

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Recent Developments in Consumer Technology and Trade Relations

Updated Category News Views 245

U.S.-China Trade Dynamics Chinese President Xi Jinping has emphasized ongoing developments in the trade relations between the U.S. and China. In a recent communication with President Donald Trump, both leaders discussed potential measures that could foster a positive trajectory for trade negotiations. Amid these discussions, reports surfaced that the U.S. is contemplating...

Continue Reading
HealthEquity Amid Allegations: An Investor's Guide to HQY

Updated Category News Views 244

Understanding the Investigation into HealthEquity, Inc. Pomerantz LLP is currently conducting a thorough investigation into the claims made by investors of HealthEquity, Inc. This action highlights potential concerns regarding the company’s business practices and the conduct of certain officers and directors. What Triggered the Investigation? The investigation centers...

Continue Reading
PetVivo AI Unveils Innovative Platform to Cut Client Costs

Updated Category News Views 147

Revolutionizing Veterinary Practices with AI PetVivo AI, Inc. is taking the veterinary world by storm with the introduction of PetVivo.ai, an innovative artificial intelligence platform aimed at transforming the pet care sector. With the pet care industry experiencing exponential growth—surpassing $150 billion—this platform promises to decrease client acquisition...

Continue Reading
Avery Dennison's Earnings Anticipation: What Investors Should Know

Updated Category News Views 126

Upcoming Earnings Report for Avery Dennison Avery Dennison (NYSE: AVY) is gearing up for a significant quarter, with expectations heightened ahead of its earnings announcement. Investors are eagerly awaiting the results, which could reveal crucial insights into the company's current performance and future direction. Analysts' Expectations Market analysts predict that...

Continue Reading
Understanding Recent Trends in HDFC Bank Ltd's Short Interest

Updated Category News Views 169

Recent Developments in HDFC Bank Ltd's Short Interest HDFC Bank Ltd (NYSE:HDB) has recently experienced a notable shift in its short interest. According to the latest information, short interest as a percentage of float has decreased by 3.23%. Currently, there are 15.25 million shares sold short, representing 0.3% of the available regular shares for trading. This change...

Continue Reading